La tecnología AdvaTab Advanced ODT facilita la ingestión en pacientes pediátricos, geriátricos y disfágicos
- Compuesto de partículas finamente micronizadas que se desintegran rápidamente en una suspensión suave y viscosa
- Una solución dosificadora fácil de tomar:
- Enmascara el sabor amargo de la droga
- Se disuelve rápidamente en la boca sin agua
- Se ha demostrado que los comprimidos AdvaTab son bioequivalentes a las fórmulas de liberación inmediata o sostenida
Formulaciones y proceso de fabricación patentados
- Advatabs® incorpora partículas de fármaco recubiertas y uniformemente dispersas en una matriz de baja humedad y rápida desintegración.
- Formulated for acceptable taste, a disintegration time <30 seconds
- Adecuado para envases blíster push-through y configuraciones de envasado múltiple
- Capacidad de carga de hasta 500 mg de fármaco
Hable con un experto
Dr. Srinivasan Shanmugam
Executive Director, Pharmaceutical Sciences, Business Support, and New Technologies
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
